These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11780335)

  • 1. LMP1 activates NF-kappa B via degradation of I kappa B alpha in nasopharyngeal carcinoma cells.
    Yin L; Liao W; Deng X; Tang M; Gu H; Li X; Yi W; Cao Y
    Chin Med J (Engl); 2001 Jul; 114(7):718-22. PubMed ID: 11780335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus LMP1 via NF-kappa B or AP-1 signaling pathway in nasopharyngeal carcinoma cells].
    Wang C; Deng X; Li X; Gu H; Yi W; Weng X; Xia L; Cao Y
    Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):9-13. PubMed ID: 11977651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference effect of epigallocatechin-3-gallate on targets of nuclear factor kappaB signal transduction pathways activated by EB virus encoded latent membrane protein 1.
    Yan Z; Yong-Guang T; Fei-Jun L; Fa-Qing T; Min T; Ya C
    Int J Biochem Cell Biol; 2004 Aug; 36(8):1473-81. PubMed ID: 15147726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-kappaB p65 in human nasopharyngeal carcinoma cells.
    Ding L; Li LL; Yang J; Tao YG; Ye M; Shi Y; Tang M; Yi W; Li XL; Gong JP; Cao Y
    Int J Biochem Cell Biol; 2005 Sep; 37(9):1881-9. PubMed ID: 15967702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappaB only partially mediates Epstein-Barr virus latent membrane protein 1 activation of B cells.
    Liljeholm S; Hughes K; Grundström T; Brodin P
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2117-25. PubMed ID: 9747720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [EBV latent membrane protein 1 induces p53 expression via NF-kappa B in nasopharyngeal carcinoma].
    Liao W; Tang M; Yin L
    Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):199-201. PubMed ID: 11783085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.
    Liu H; Zheng H; Duan Z; Hu D; Li M; Liu S; Li Z; Deng X; Wang Z; Tang M; Shi Y; Yi W; Cao Y
    Mol Cancer; 2009 Oct; 8():92. PubMed ID: 19860880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma.
    Wang C; Ai M; Ren W; Xiao H; Li X; Tang F; Gu H; Yi W; Weng X; Deng X; Cao Y
    Chin Med J (Engl); 2003 Jul; 116(7):1022-8. PubMed ID: 12890376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway.
    Eliopoulos AG; Caamano JH; Flavell J; Reynolds GM; Murray PG; Poyet JL; Young LS
    Oncogene; 2003 Oct; 22(48):7557-69. PubMed ID: 14576817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated expression of kappa light chain by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cells via NF-kappaB and AP-1 pathways.
    Liu HD; Zheng H; Li M; Hu DS; Tang M; Cao Y
    Cell Signal; 2007 Feb; 19(2):419-27. PubMed ID: 16979873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus LMP1 initiates cell proliferation and apoptosis inhibition via regulating expression of Survivin in nasopharyngeal carcinoma.
    Faqing T; Zhi H; Liqun Y; Min T; Huanhua G; Xiyun D; Ya C
    Exp Oncol; 2005 Jun; 27(2):96-101. PubMed ID: 15995625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells.
    Lo AK; Huang DP; Lo KW; Chui YL; Li HM; Pang JC; Tsao SW
    Int J Cancer; 2004 May; 109(6):919-25. PubMed ID: 15027126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells.
    Murono S; Inoue H; Tanabe T; Joab I; Yoshizaki T; Furukawa M; Pagano JS
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6905-10. PubMed ID: 11381123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells.
    Yang J; Deng X; Deng L; Gu H; Fan W; Cao Y
    J Exp Clin Cancer Res; 2004 Sep; 23(3):495-506. PubMed ID: 15595642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma.
    Chen CC; Liu HP; Chao M; Liang Y; Tsang NM; Huang HY; Wu CC; Chang YS
    Oncogene; 2014 Jul; 33(28):3648-59. PubMed ID: 23975427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation of NF-kappa B activity by Epstein-Barr virus (EBV) LMP1 as a selective therapeutic strategy for EBV-associated diseases.
    Wu CJ; Leu CY; Liu ST; Chow KP; Meng CL; Chang YS
    Gene Ther; 1998 Jul; 5(7):905-12. PubMed ID: 9813661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.
    Song YJ; Jen KY; Soni V; Kieff E; Cahir-McFarland E
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2689-94. PubMed ID: 16477006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells.
    Dawson CW; Eliopoulos AG; Blake SM; Barker R; Young LS
    Virology; 2000 Jun; 272(1):204-17. PubMed ID: 10873763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway.
    Vockerodt M; Tesch H; Kube D
    Genes Immun; 2001 Dec; 2(8):433-41. PubMed ID: 11781710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.